RecruitingNCT05802836

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Christoph Königs
Principal Investigator
Christoph Koenigs, PD Dr. Dr
Goethe University
Intervention
no interventions(other)
Enrollment
100 enrolled
Eligibility
All sexes
Timeline
2023 – 2029

Study locations (1)

Collaborators

Roche Pharma AG · Chugai Pharma Germany GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05802836 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials